Lucid Diagnostics Stock Price Prediction
| LUCD Stock | USD 0.79 0.02 2.60% |
Oversold Vs Overbought
56
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (0.76) | EPS Estimate Next Year (0.52) | Wall Street Target Price 3.5 | EPS Estimate Current Quarter (0.22) |
Using Lucid Diagnostics hype-based prediction, you can estimate the value of Lucid Diagnostics from the perspective of Lucid Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lucid Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Lucid because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lucid Diagnostics after-hype prediction price | USD 0.79 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lucid |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of Lucid Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lucid Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lucid Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lucid Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Lucid Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lucid Diagnostics' historical news coverage. Lucid Diagnostics' after-hype downside and upside margins for the prediction period are 0.04 and 3.86, respectively. We have considered Lucid Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lucid Diagnostics is very risky at this time. Analysis and calculation of next after-hype price of Lucid Diagnostics is based on 3 months time horizon.
Lucid Diagnostics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lucid Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lucid Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lucid Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 3.07 | 0.00 | 0.01 | 9 Events / Month | 11 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.79 | 0.79 | 0.00 |
|
Lucid Diagnostics Hype Timeline
Lucid Diagnostics is now traded for 0.79. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Lucid is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.07%. %. The volatility of related hype on Lucid Diagnostics is about 1752.22%, with the expected price after the next announcement by competition of 0.80. About 59.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.12. Lucid Diagnostics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Lucid Diagnostics Basic Forecasting Models to cross-verify your projections.Lucid Diagnostics Related Hype Analysis
Having access to credible news sources related to Lucid Diagnostics' direct competition is more important than ever and may enhance your ability to predict Lucid Diagnostics' future price movements. Getting to know how Lucid Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lucid Diagnostics may potentially react to the hype associated with one of its peers.
Lucid Diagnostics Additional Predictive Modules
Most predictive techniques to examine Lucid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lucid using various technical indicators. When you analyze Lucid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lucid Diagnostics Predictive Indicators
The successful prediction of Lucid Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lucid Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lucid Diagnostics based on analysis of Lucid Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lucid Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lucid Diagnostics's related companies. | 2010 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.39 | 3.42 | 5.22 | 5.48 | Days Of Inventory On Hand | 307.6 | 11.21 | 16.97 | 16.12 |
Story Coverage note for Lucid Diagnostics
The number of cover stories for Lucid Diagnostics depends on current market conditions and Lucid Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lucid Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lucid Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lucid Diagnostics Short Properties
Lucid Diagnostics' future price predictability will typically decrease when Lucid Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lucid Diagnostics often depends not only on the future outlook of the potential Lucid Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lucid Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.8 M | |
| Cash And Short Term Investments | 18.9 M |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |